Drug intelligence / Profile preview

low-titer group o+ non-leukoreduced whole blood

Development stage
Unknown
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

**Low-titer group O+ non-leukoreduced whole blood (LTOWB)** is a complete blood product collected from group O RhD-positive donors with low levels of anti-A and anti-B antibodies (typically titers <256, varying by blood center). It contains red blood cells, cold-stored platelets, and plasma in a single unit, stored cold for up to 21 days, and is non-leukocyte-reduced. Primarily indicated for rapid, balanced resuscitation in life-threatening hemorrhage, such as trauma, where oxygen-carrying capacity, coagulation factors, platelets, and volume expansion are needed urgently, especially when patient blood type is unknown. It serves as a universal donor product, simplifying logistics over separate components, reducing donor exposures, and minimizing dilutional coagulopathy risks.[1][2][3]

Other names
LTOWBlow titer group O whole bloodlow-titer O+ whole blood

Beyond the preview

Go deeper on low-titer group o+ non-leukoreduced whole blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low-titer group o+ non-leukoreduced whole blood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call